Dr. Reddy's Laboratories Limited Share Price NSE India S.E.
Equities
DRREDDY
INE089A01023
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,908 INR | +0.66% | -2.46% | +1.89% |
Sales 2024 | 280B 3.36B | Sales 2025 * | 300B 3.6B | Capitalization | 978B 11.71B |
---|---|---|---|---|---|
Net income 2024 | 55.78B 668M | Net income 2025 * | 55.48B 665M | EV / Sales 2024 | 3.43 x |
Net cash position 2024 | 64.59B 774M | Net cash position 2025 * | 90.85B 1.09B | EV / Sales 2025 * | 2.95 x |
P/E ratio 2024 |
18.4
x | P/E ratio 2025 * |
17.5
x | Employees | 25,863 |
Yield 2024 |
0.65% | Yield 2025 * |
0.77% | Free-Float | 91.55% |
Latest transcript on Dr. Reddy's Laboratories Limited
1 day | +1.04% | ||
1 week | -2.09% | ||
Current month | -4.42% | ||
1 month | -1.34% | ||
3 months | -5.16% | ||
6 months | +9.41% | ||
Current year | +2.28% |
Managers | Title | Age | Since |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 02/18/02 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 02/20/02 |
Chairman | 56 | 18/93/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 08/86/08 |
Chairman | 56 | 18/93/18 | |
Kalpana Morparia
BRD | Director/Board Member | 74 | 05/07/05 |
Date | Price | Change | Volume |
---|---|---|---|
15/24/15 | 5,908 | +0.66% | 222 178 |
14/24/14 | 5,869 | -0.67% | 237,330 |
13/24/13 | 5,909 | -0.21% | 170,564 |
10/24/10 | 5,921 | +0.74% | 296,180 |
09/24/09 | 5,877 | -2.96% | 506,907 |
Delayed Quote NSE India S.E., May 15, 2024 at 11:42 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.06% | 688B | |
+30.35% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.53% | 239B | |
+10.16% | 210B | |
-8.14% | 200B | |
+8.12% | 167B |
- Stock Market
- Equities
- DRREDDY Stock
- DRREDDY Stock